Trials / Completed
CompletedNCT03140748
Kinetics of Serum β-D-glucan During Peritonitis With Candida in Resuscitation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- Centre Hospitalier Universitaire, Amiens · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Intraabdominal fungal infections with Candida are constantly increasing. Their diagnosis and treatment is difficult. Morbidity and mortality are high. Β-D-Glucan has been proposed as a marker of systemic fungal infection in candidemia. Moreover, its kinetics is associated with therapeutic success. On the other hand, there are no data on intraabdominal infections that are much more frequent. The objective of the study is to evaluate the initial levels of β-D-glucan and its daily kinetics during the treatment of fungal peritonitis in resuscitation compared to a control group with a yeast-free peritonitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | To evaluate the initial levels and kinetics of serum β-D-glucan | To evaluate the initial levels and kinetics of serum β-D-glucan during fungal peritonitis compared to a control group of yeast-free peritonitis |
Timeline
- Start date
- 2018-05-01
- Primary completion
- 2021-08-22
- Completion
- 2023-06-01
- First posted
- 2017-05-04
- Last updated
- 2025-09-19
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03140748. Inclusion in this directory is not an endorsement.